|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
CoMentis, Inc.
| CoMentis, Inc. 400 Oyster Point Blvd., Suite 226 South San Fransisco, CA 94080 | |
| | Phone: | (650) 869-7600 | Fax: | (650) 869-7626 | Year Established: | 2004 | Main Contact: | Terence A. Kelly, Ph.D., President & CEO | | Other Contacts: | Gerald Koelsch, Ph.D., VP, Neurobiology John Ng, Ph.D., VP, R&D Operations Geoff Bilcer, PhD, VP, Medicinal Chemistry Michael Detke, MD, PhD, CMO Daniel Hunt, General Counsel, VP Corporate Development
| | Company Description | CoMentis (formerly Athenagen) a biotech company, engages in the research, discovery, and development of small-molecule drugs to treat neurological diseases
, with a focus on Alzheimer's disease and Schizophrenia. The company advanced the first beta-secretase inhibitor into the clinic for the treatment of Alzheimer's disease in 2006. The current focus of the company is the development of nicotinic acetylcholine receptor modulators for the treatment of cognitive disorders. | |
|
|
|
|
|